Detalhe da pesquisa
1.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
N Engl J Med
; 388(23): 2145-2158, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972026
2.
Guideline concordant care for patients with locally advanced cervical cancer by disaggregated Asian American and Native Hawaiian/Pacific Islander groups: A National Cancer Database Analysis.
Gynecol Oncol
; 182: 132-140, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262236
3.
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
Gynecol Oncol
; 184: 168-177, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325276
4.
Demographic reporting and language exclusion in gynecologic oncology clinical trials.
Am J Obstet Gynecol
; 230(1): 73.e1-73.e14, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751830
5.
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary.
Future Oncol
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501262
6.
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.
Int J Gynecol Cancer
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627035
7.
Missed opportunities in the real-world genetic testing in BRCA gene variant carriers with cancers meeting NCCN criteria.
Gynecol Oncol
; 170: 32-37, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36610379
8.
Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers.
Gynecol Oncol
; 170: 234-240, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724586
9.
Improving genetic testing following abnormal mismatch repair immunohistochemistry results in endometrial cancer.
Gynecol Oncol
; 175: 20-24, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290248
10.
Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
Gynecol Oncol
; 179: 131-137, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988946
11.
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes.
Gynecol Oncol
; 178: 44-53, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748270
12.
A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer.
Future Oncol
; 19(25): 1709-1714, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381977
13.
Frequency of actionable germline pathogenic variants identified through tumor next-generation sequencing in a gynecologic cancer cohort.
Int J Gynecol Cancer
; 33(7): 1044-1050, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889816
14.
Biomarker-driven therapy in endometrial cancer.
Int J Gynecol Cancer
; 33(3): 343-350, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878569
15.
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions.
Int J Gynecol Cancer
; 33(11): 1733-1742, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931976
16.
Treatment options for molecular subtypes of endometrial cancer in 2023.
Curr Opin Obstet Gynecol
; 35(3): 270-278, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943683
17.
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 381(25): 2391-2402, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562799
18.
Utility of germline multi-gene panel testing in patients with endometrial cancer.
Gynecol Oncol
; 165(3): 546-551, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483985
19.
Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry study.
Gynecol Oncol
; 167(2): 146-151, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36154761
20.
COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic.
Gynecol Oncol
; 164(2): 304-310, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922769